{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:15:44Z","timestamp":1784690144090,"version":"3.55.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-025-01039-4","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T19:03:51Z","timestamp":1740078231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AI-Driven Analysis of Drug Marketing Efficiency: Unveiling FDA Approval to Market Release Dynamics"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1826-742X","authenticated-orcid":false,"given":"Yoshiyasu","family":"Takefuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"1039_CR1","unstructured":"Data.Gov. Drug Products in the Medicaid Drug Rebate Program. 2023. https:\/\/catalog.data.gov\/dataset\/drug-products-in-the-medicaid-drug-rebate-program-2933e\/resource\/f25e01e5-10cc-45d8-9eaa-1e4a746ddba1.\u00a0Accessed 7 Feb 2025."},{"key":"1039_CR2","doi-asserted-by":"publisher","unstructured":"Rathore AS, Li Y, Chhabra H, Lohiya A. FDA Warning Letters: A Retrospective Analysis of Letters Issued to Pharmaceutical Companies from 2010\u20132020. J Pharm Innov. 2022;1\u201310. Advance online publication. \nhttps:\/\/doi.org\/10.1007\/s12247-022-09678-2.","DOI":"10.1007\/s12247-022-09678-2"},{"issue":"3","key":"1039_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/healthcare11030447","volume":"11","author":"M Ciulla","year":"2023","unstructured":"Ciulla M, Marinelli L, Di Biase G, Cacciatore I, Santoleri F, Costantini A, Dimmito MP, Di Stefano A. Healthcare systems across Europe and the US: the managed entry agreements experience. Healthcare (Basel, Switzerland). 2023;11(3):447. https:\/\/doi.org\/10.3390\/healthcare11030447.","journal-title":"Healthcare (Basel, Switzerland)"},{"issue":"2","key":"1039_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jacbts.2022.12.011","volume":"8","author":"GA Van Norman","year":"2023","unstructured":"Van Norman GA. Off-label use vs off-label marketing of drugs: part 1: off-label use-patient harms and prescriber responsibilities. JACC Basic Transl Sci. 2023;8(2):224\u201333. https:\/\/doi.org\/10.1016\/j.jacbts.2022.12.011.","journal-title":"JACC Basic Transl Sci"},{"key":"1039_CR5","unstructured":"FDA.GOV. Drug Approval Process. 2023. https:\/\/www.fda.gov\/media\/82381\/download.\u00a0Accessed 7 Feb 2025."},{"key":"1039_CR6","unstructured":"FDA.GOV. New Drug Application (NDA). 2023. https:\/\/www.fda.gov\/drugs\/types-applications\/new-drug-application-nda.\u00a0Accessed 7 Feb 2025."},{"issue":"10","key":"1039_CR7","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.2105\/AJPH.2021.306425","volume":"111","author":"PJ Zettler","year":"2021","unstructured":"Zettler PJ, Shah SK. Broader implications of eliminating FDA jurisdiction over execution drugs. Am J Public Health. 2021;111(10):1764\u20137. https:\/\/doi.org\/10.2105\/AJPH.2021.306425.","journal-title":"Am J Public Health"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01039-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-025-01039-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-025-01039-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T16:02:17Z","timestamp":1742832137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-025-01039-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":7,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1039"],"URL":"https:\/\/doi.org\/10.1208\/s12248-025-01039-4","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"48"}}